These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21815171)

  • 1. Development and characterization of skin permeation retardants and enhancers: a comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles.
    Azarbayjani AF; Khu JV; Chan YW; Chan SY
    Biopharm Drug Dispos; 2011 Oct; 32(7):380-8. PubMed ID: 21815171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
    Haddadi A; Farboud ES; Erfan M; Aboofazeli R
    J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.
    Jilek S; Ulrich M; Merkle HP; Walter E
    Pharm Res; 2004 Jul; 21(7):1240-7. PubMed ID: 15290866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents.
    Chaw CS; Tan CW; Yang YY; Wang L; Moochhala S
    Biomaterials; 2003 Mar; 24(7):1271-7. PubMed ID: 12527268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altering the drug release profiles of double-layered ternary-phase microparticles.
    Lee WL; Loei C; Widjaja E; Loo SC
    J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation.
    Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD
    J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles.
    Naha PC; Kanchan V; Panda AK
    J Biomater Appl; 2009 Nov; 24(4):309-25. PubMed ID: 18987018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.
    Ozeki T; Beppu S; Mizoe T; Takashima Y; Yuasa H; Okada H
    Pharm Res; 2006 Jan; 23(1):177-83. PubMed ID: 16267631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
    Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
    Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.